These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 27207155)

  • 1. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
    Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
    Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.
    Ahmad A; Bromberg DJ; Shrestha R; Salleh NM; Bazazi AR; Kamarulzaman A; Shenoi S; Altice FL
    Int J Drug Policy; 2024 Apr; 126():104369. PubMed ID: 38484531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
    Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
    J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments.
    Azbel L; Wegman MP; Polonsky M; Bachireddy C; Meyer J; Shumskaya N; Kurmanalieva A; Dvoryak S; Altice FL
    Int J Prison Health; 2018 Sep; 14(3):175-187. PubMed ID: 30274558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
    Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
    BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
    Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
    Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: implications for secondary prevention.
    Bachireddy C; Bazazi AR; Kavasery R; Govindasamy S; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2011 Jul; 116(1-3):151-7. PubMed ID: 21232882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
    Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
    Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and implementation of a factorial randomized controlled trial of methadone maintenance therapy and an evidence-based behavioral intervention for incarcerated people living with HIV and opioid dependence in Malaysia.
    Bazazi AR; Wickersham JA; Wegman MP; Culbert GJ; Pillai V; Shrestha R; Al-Darraji H; Copenhaver MM; Kamarulzaman A; Altice FL
    Contemp Clin Trials; 2017 Aug; 59():1-12. PubMed ID: 28479216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A qualitative inquiry into methadone maintenance treatment for opioid-dependent prisoners in Tehran, Iran.
    Zamani S; Farnia M; Tavakoli S; Gholizadeh M; Nazari M; Seddighi AA; Setayesh H; Afshar P; Kihara M
    Int J Drug Policy; 2010 May; 21(3):167-72. PubMed ID: 19395250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
    Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
    J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
    Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
    Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unfavorable attitudes toward receiving methadone maintenance therapy and associated factors among the inmates using intravenous heroin.
    Yen CF; Tsai JJ; Wang PW; Yeh YC; Liu SC; Wang SH; Wang CC
    Kaohsiung J Med Sci; 2011 Jan; 27(1):25-31. PubMed ID: 21329889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing methadone maintenance treatment in prisons in Malaysia.
    Wickersham JA; Marcus R; Kamarulzaman A; Zahari MM; Altice FL
    Bull World Health Organ; 2013 Feb; 91(2):124-9. PubMed ID: 23554524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
    Zhao Y; Shi CX; McGoogan JM; Rou K; Zhang F; Wu Z
    Addiction; 2015 Jan; 110 Suppl 1(Suppl 1):40-50. PubMed ID: 25533863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.
    Damon W; Small W; Anderson S; Maher L; Wood E; Kerr T; McNeil R
    Drug Alcohol Rev; 2017 Mar; 36(2):253-260. PubMed ID: 27126765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in clinical trials after prison release: results from a clinical trial with incarcerated men with HIV and opioid dependence in Malaysia.
    Chandra DK; Bazazi AR; Nahaboo Solim MA; Kamarulzaman A; Altice FL; Culbert GJ
    HIV Res Clin Pract; 2019 Feb; 20(1):12-23. PubMed ID: 31303149
    [No Abstract]   [Full Text] [Related]  

  • 19. Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study.
    O'Hara GL; Liberman AR; Polonsky M; Azbel L; Marcus R; Doltu S; Cugut S; Altice FL
    J Subst Abuse Treat; 2022 May; 136():108660. PubMed ID: 34801282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor structure, internal reliability and construct validity of the Methadone Maintenance Treatment Stigma Mechanisms Scale (MMT-SMS).
    Smith LR; Mittal ML; Wagner K; Copenhaver MM; Cunningham CO; Earnshaw VA
    Addiction; 2020 Feb; 115(2):354-367. PubMed ID: 31478272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.